Healthlead Stock

HL

THA598010009

Drug Retailers

End-of-day quote Thailand S.E. 29/09/2026			5-day change	1st Jan Change
4.480 ^THB	0.00%		-0.44%	-37.78%

08-17	Healthlead Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-14	Tranche Update on Healthlead Public Company Limited (SET:HL)'s Equity Buyback Plan announced on May 11, 2026.	CI

Healthlead Public Company Limited is a Thailand-based company involved in the pharmacy business, distributing medicines, medical supplies, cosmeceuticals, supplements, medical devices, and other healthcare products. The Company is also engaged in the invention, development, import, and distribution of healthcare products. Its businesses include Icare Health and Healthiness. Icare Health business operates pharmacies that sell more than 10,000 stock-keeping units (SKUs) of medicines, medical supplies, cosmeceuticals, dietary supplements, medical equipment, and healthcare products. Its pharmacies operate under four brands: iCare, Pharmax, Vitaminclub, and Super Drug. The Healthiness business develops its products in collaboration with external researchers. These products and innovations are marketed under two brands: PRIME and Besuto. Its brands also include BOMSKIN. The Companyâ€™s subsidiaries are Icare Health Co., Ltd. and Healthiness Co., Ltd. It operates approximately 64 branches.

Employees

Sector

Drug Retailers

More about the company

Quotes

Date	Price	Change	Volume
29/09/26	THB 4.480	0.00%	24,906
28/09/26	THB 4.480	0.00%	92,318
25/09/26	THB 4.480	0.00%	11,331
24/09/26	THB 4.480	0.00%	85,234
23/09/26	THB 4.480	0.00%	36,237

End-of-day quote Thailand S.E.

More quotes

Annual profits - Rate of surprise

Company calendar

Market Cap	1.14B 33.91M 29.91M 28.27M 25.62M 48.09M 3.25B 48.5M 339M 131M 1.66B 127M 125M 5.39B	P/E 2024	35.4x	P/E 2025	24.8x
Enterprise Value	906M 27.03M 23.84M 22.53M 20.42M 38.33M 2.59B 38.65M 270M 104M 1.33B 101M 99.26M 4.3B	EV / Sales 2024	1.27x	EV / Sales 2025	0.73x
Free-Float	21.21%	Yield 2024	1.67%	Yield 2025	3.06%

08-17	Healthlead Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-14	Tranche Update on Healthlead Public Company Limited (SET:HL)'s Equity Buyback Plan announced on May 11, 2026.	CI
05-11	Healthlead Public Company Limited (SET:HL) announces an Equity Buyback for 6,000,000 shares, representing 2.21% for THB 42 million.	CI
05-08	Healthlead Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-08	Healthlead Public Company Limited authorizes a Buyback Plan.	CI
04-30	Healthlead Public Company Limited's Equity Buyback announced on December 8, 2025, has expired.	CI
03-09	Healthlead Public Company Limited Announces Retirement of Rathpong Ratanahirunya as Independent Director, Effective 24 April, 2026	CI
02-26	Healthlead Public Company Limited Announces Board Changes, Effective February 26, 2026	CI
02-26	Healthlead Public Company Limited Announces CEO Changes, Effective March 1, 2026	CI
02-26	Healthlead Public Company Limited announces Annual dividend, payable on May 15, 2026	CI
02-25	Healthlead Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12-08	Healthlead Public Company Limited (SET:HL) announces an Equity Buyback for 9,000,000 shares, representing 3.31% for THB 65 million.	CI
12-08	Healthlead Public Company Limited authorizes a Buyback Plan.	CI

01/06/22	Healthlead Public : Changing of Chief Accountant	PU
22/04/22	Healthlead Public : To report the resolutions of the 2022 Annual General Meeting of Shareholders	PU
31/03/22	Healthlead Public : Publication of Invitation to the 2022 Annual General Meeting of Shareholders on the Company's Website	PU

1 week	-0.44%
Current month	-7.44%
1 month	-7.44%
3 months	-18.55%
6 months	-27.74%
Current year	-37.78%

1 week	4.46	4.52
1 month	4.46	4.94
Current year	4.46	7.35
1 year	4.46	8.45
3 years	4.46	12.6
5 years	4.46	32
10 years	4.46	32

Healthlead Stock

Stocks

HL

THA598010009

Drug Retailers

Valuation: Healthlead

Chart: Healthlead

Latest news: Healthlead

Press Releases: Healthlead

Quotes and Performance

Price Extremes

Managers and Directors: Healthlead

Latest insider transactions

Other Drug Retailers

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

Manager	Title	Age	Since
Supakorn Bhandhukanonda CEO	Chief Executive Officer	38	01/03/2026
Araya Tantanasin DFI	Director of Finance/CFO	56	01/01/2019
Sasithon Marukasonthi AUD	Comptroller/Controller/Auditor	-	01/09/2022

Director	Title	Age	Since
Apirudee Hemajutha CHM	Chairman	70	01/04/2020
Marayad Teeratomorn BRD	Director/Board Member	57	01/04/2020
Thanasak Kulrattanarak BRD	Director/Board Member	52	01/04/2020

Date	Insider	Type	Main position	Quantity	% Market Cap.	Importance
03/04/25	Supakorn Bhandhukanonda	Buy	Chief Executive Officer	42,800	0.0157%
02/04/25	Supakorn Bhandhukanonda	Buy	Chief Executive Officer	50,000	0.0184%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
HEALTHLEAD	0.00%	-0.44%	-41.05%	-61.71%	33.84M
JD HEALTH INTERNATIONAL INC.	+1.41%	-0.83%	-44.12%	-4.28%	14.45B
MATSUKIYOCOCOKARA & CO.	-1.30%	-4.01%	-21.26%	-9.24%	6.22B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-0.53%	-3.58%	-54.51%	-35.94%	5.85B
YIFENG PHARMACY CHAIN CO., LTD.	+2.40%	+3.88%	-7.29%	-21.27%	4.06B
NAHDI MEDICAL COMPANY	-0.27%	-1.89%	-20.08%	-36.93%	3.16B
CLICKS GROUP LIMITED	+1.04%	+3.25%	-39.97%	-16.71%	3.03B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	+0.34%	-0.67%	+4.21%	-29.11%	3.01B
GUARDIAN PHARMACY SERVICES, INC.	-0.15%	-7.88%	+56.40%	-	2.58B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	-0.29%	-2.29%	-30.10%	-14.47%	2.25B
Average	+0.15%	-0.23%	-19.78%	-25.52%	4.46B
Weighted average by Cap.	+0.32%	-0.29%	-27.19%	-16.77%

	2024	2025
Net sales	2.01B 59.97M 52.9M 49.99M 45.31M 85.05M 5.76B 85.77M 599M 231M 2.94B 225M 220M 9.54B	2.27B 67.68M 59.69M 56.41M 51.13M 95.98M 6.5B 96.79M 676M 261M 3.32B 254M 249M 10.76B
Net income	78.26M 2.33M 2.06M 1.95M 1.76M 3.31M 224M 3.34M 23.32M 8.99M 114M 8.76M 8.57M 371M	77.86M 2.32M 2.05M 1.94M 1.75M 3.29M 223M 3.32M 23.2M 8.94M 114M 8.72M 8.53M 369M
Net Debt	-220M -6.56M -5.79M -5.47M -4.96M -9.31M -630M -9.39M -65.6M -25.27M -322M -24.65M -24.11M -1.04B	-231M -6.88M -6.07M -5.74M -5.2M -9.76M -661M -9.85M -68.81M -26.51M -338M -25.85M -25.29M -1.09B